Although PD-L1 is overexpressed in glioma, some studies have shown that the expression level of PD-L1 varies greatly among gliomas of different grades and molecular subtypes, ranging from 6.1% to 88% (47). This evidence concerns the gene CD274 and central nervous system cancer.